Fusilev (Spectrum Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Fusilev drug offered from Spectrum Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Spectrum Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | levoleucovorin |
| SUBSTANCE NAME: | LEVOLEUCOVORIN CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-09-15 |
| END MARKETING DATE: | 0000-00-00 |
Fusilev HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fusilev from Spectrum Pharmaceuticals, Inc. |
| LABELER NAME: | Spectrum Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2011-09-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68152-102_47e3f48c-6c9e-4116-94a7-a08d4ffa4f6f |
| PRODUCT NDC: | 68152-102 |
| APPLICATION NUMBER: | NDA020140 |
Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers:
